Nicotinic Receptors, Amyloid-β, and Synaptic Failure in Alzheimer’s Disease

被引:0
|
作者
Sofia Jürgensen
Sergio T. Ferreira
机构
[1] Federal University of Rio de Janeiro,Institute of Medical Biochemistry
来源
Journal of Molecular Neuroscience | 2010年 / 40卷
关键词
Alzheimer’s disease; Nicotinic receptors; Amyloid-β;
D O I
暂无
中图分类号
学科分类号
摘要
Dysfunctional cholinergic transmission is thought to underlie, at least in part, memory impairment and cognitive deficits in Alzheimer’s disease (AD). However, it is still unclear whether this is a consequence of the loss of cholinergic neurons and elimination of nicotinic acetycholine receptors (nAChRs) in AD brain or of a direct impact of molecular interactions of the amyloid-β (Aβ) peptide with nAChRs, leading to dysregulation of receptor function. This review examines recent progress in our understanding of the roles of nicotinic receptors in mechanisms of synaptic plasticity, molecular interactions of Aβ with nAChRs, and how Aβ-induced dysregulation of nicotinic receptor function may underlie synaptic failure in AD.
引用
收藏
页码:221 / 229
页数:8
相关论文
共 50 条
  • [21] Reexamining Alzheimer's Disease: Evidence for a Protective Role for Amyloid-β Protein Precursor and Amyloid-β
    Castellani, Rudy J.
    Lee, Hyoung-gon
    Siedlak, Sandra L.
    Nunomura, Akihiko
    Hayashi, Takaaki
    Nakamura, Masao
    Zhu, Xiongwei
    Perry, George
    Smith, Mark A.
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 18 (02) : 447 - 452
  • [22] Monocytes in the Peripheral Clearance of Amyloid-β and Alzheimer's Disease
    Guo, Huifang
    Zhao, Zhaohua
    Zhang, Ruisan
    Chen, Peng
    Zhang, Xiaohua
    Cheng, Fan
    Gou, Xingchun
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (04) : 1391 - 1400
  • [23] Amyloid-β oligomers in cellular models of Alzheimer's disease
    Fontana, Igor C.
    Zimmer, Aline R.
    Rocha, Andreia S.
    Gosmann, Grace
    Souza, Diogo O.
    Lourenco, Mychael, V
    Ferreira, Sergio T.
    Zimmer, Eduardo R.
    JOURNAL OF NEUROCHEMISTRY, 2020, 155 (04) : 348 - 369
  • [24] Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer's Disease
    Blennow, Kaj
    Hampel, Harald
    Zetterberg, Henrik
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 (01) : 189 - 201
  • [25] Alzheimer's disease amyloid-β pathology in the lens of the eye
    Moncaster, Juliet A.
    Moir, Robert D.
    Burton, Mark A.
    Chadwick, Oliver
    Minaeva, Olga
    Alvarez, Victor E.
    Ericsson, Maria
    Clark, John I.
    McKee, Ann C.
    Tanzi, Rudolph E.
    Goldstein, Lee E.
    EXPERIMENTAL EYE RESEARCH, 2022, 221
  • [26] Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease
    Pinheiro, Lidia
    Faustino, Celia
    CURRENT ALZHEIMER RESEARCH, 2019, 16 (05) : 418 - 452
  • [27] Targeted proteomics in Alzheimer's disease:: focus on amyloid-β
    Portelius, Erik
    Zetterberg, Henrik
    Gobom, Johan
    Andreasson, Ulf
    Blennow, Kaj
    EXPERT REVIEW OF PROTEOMICS, 2008, 5 (02) : 225 - 237
  • [28] The amyloid-β peptide and its role in Alzheimer's disease
    Clippingdale, AB
    Wade, JD
    Barrow, CJ
    JOURNAL OF PEPTIDE SCIENCE, 2001, 7 (05) : 227 - 249
  • [29] Pathological Changes Induced by Amyloid-β in Alzheimer's Disease
    Takata, Kazuyuki
    Kitamura, Yoshihisa
    Taniguchi, Takashi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2011, 131 (01): : 3 - 11
  • [30] Spherulites of Amyloid-β42 In Vitro and in Alzheimer's Disease
    Exley, Christopher
    House, Emily
    Collingwood, Joanna F.
    Davidson, Mark R.
    Cannon, Danielle
    Donald, Athene M.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (04) : 1159 - 1165